Xiling Lab

Driven by innovation and cooperation, it provides safe and effective innovative drugs for patients in China and the world. Xiling Lab Pharmaceutical Co., Ltd. was established in August 2016, owns Chengdu kelingyuan Pharmaceutical Technology Co., Ltd. and Guixi PharmaTech Pty Ltd. in Australia. Xiling Lab has the qualification of "national high tech... enterprise", and its core technology and management team have been awarded the title of "top innovation and entrepreneurship team" in Sichuan Province and Chengdu City. Xiling Lab is committed to building an internationally leading platform for small molecule drug concept validation, contrast agent drug development and catalytic technology. The company emphasizes practical innovation. At present, it has applied for more than 20 invention patents, of which 3 have completed the transfer of development rights, which has achieved considerable economic benefits for the companyRead More